3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Neoplastic Processes
1
Myeloproliferative Disorders
1
Leukemia
1
Hematologic Diseases
1
Bronchiolitis Obliterans Syndrome
1
Bone Marrow Diseases
1
Interventions
trastuzumab deruxtecan
4
eribulin
3
Capecitabine
3
Trastuzumab
2
Paclitaxel
2
Gemcitabine
2
Carboplatin
2
130-nm albumin-bound paclitaxel
2
telisotuzumab vedotin
1
taxane
1
pertuzumab
1
pembrolizumab
1
osimertinib
1
olaparib
1
margetuximab
1
exemestane
1
entrectinib
1
encorafenib
1
dacomitinib
1
capmatinib
1
binimetinib
1
adagrasib
1
abemaciclib
1
Vinorelbine
1
Vemurafenib
1
Pemetrexed
1
Imlunestrant
1
Gefitinib
1
Fulvestrant
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Neoplasm Metastasis
×
nilotinib
×
Clear all
No trials found.